JD HEALTH
06618
ALI HEALTH
00241
KUAISHOU-W
01024
4
JD-SW
09618
5
TRIP.COM-S
09961
| (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 16.53%9.11B | 16.01%4.39B | 13.84%7.82B | 22.28%3.78B | 7.58%6.87B | -0.41%3.09B | 14.22%6.38B | 15.29%3.11B | 5.07%5.59B | 1.98%2.7B |
| Operating income | 16.53%9.11B | 16.01%4.39B | 13.84%7.82B | 22.28%3.78B | 7.58%6.87B | -0.41%3.09B | 14.22%6.38B | 15.29%3.11B | 5.07%5.59B | 1.98%2.7B |
| Cost of sales | -8.97%-1.28B | -1.68%-592.05M | 1.66%-1.17B | -10.01%-582.28M | -7.94%-1.19B | -1.79%-529.29M | -4.08%-1.11B | -8.76%-519.99M | -14.87%-1.06B | -4.29%-478.1M |
| Operating expenses | -8.97%-1.28B | -1.68%-592.05M | 1.66%-1.17B | -10.01%-582.28M | -7.94%-1.19B | -1.79%-529.29M | -4.08%-1.11B | -8.76%-519.99M | -14.87%-1.06B | -4.29%-478.1M |
| Gross profit | 17.87%7.83B | 18.61%3.8B | 17.10%6.64B | 24.81%3.2B | 7.50%5.67B | -0.85%2.57B | 16.60%5.28B | 16.69%2.59B | 3.00%4.52B | 1.49%2.22B |
| Selling expenses | -11.48%-3.35B | -15.95%-1.59B | -16.50%-3.01B | -19.51%-1.37B | -11.04%-2.58B | 0.15%-1.15B | -15.07%-2.32B | -18.49%-1.15B | -3.54%-2.02B | 2.68%-972.27M |
| Administrative expenses | -4.39%-501.95M | 6.17%-201.2M | -22.21%-480.83M | -8.23%-214.42M | -5.91%-393.43M | -18.36%-198.12M | 17.95%-371.49M | -12.50%-167.38M | 33.02%-452.78M | 69.07%-148.79M |
| Research and development expenses | -66.90%-1.33B | -55.33%-476.23M | -14.55%-794.79M | -4.16%-306.59M | 7.97%-693.81M | 14.65%-294.34M | -27.70%-753.87M | -35.58%-344.85M | -12.11%-590.34M | 3.62%-254.35M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | -12.94%-36.52M | 17.94%-66.53M | 25.88%-32.33M | 25.95%-81.07M | ---43.62M |
| Special items of operating profit | 36.41%-88.55M | 470.17%45.46M | -133.73%-139.25M | -105.04%-12.28M | 182.64%412.79M | 60.81%243.86M | 139.33%146.05M | 294.12%151.65M | -456.74%-371.3M | 186.48%38.48M |
| Operating profit | 15.29%2.56B | 21.49%1.57B | -8.11%2.22B | 14.49%1.29B | 26.80%2.42B | 8.40%1.13B | 88.79%1.91B | 24.59%1.04B | -18.19%1.01B | 84.25%836.53M |
| Financing cost | 10.10%-190.85M | -17.41%-104.35M | -106.62%-212.3M | ---88.88M | ---102.75M | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | 1,236.41%350.56M | -276.21%-44.41M | 2.66%-30.85M | 2.41%-11.81M | 6.58%-31.69M | 19.72%-12.1M | -13.58%-33.92M | 16.72%-15.07M | -86.66%-29.87M | -631.92%-18.09M |
| Share of profit from joint venture company | -254.61%-1.63M | -165.43%-814K | 141.21%1.05M | 290.21%1.24M | 19.60%-2.56M | 48.83%-654K | -505.33%-3.18M | -1,026.09%-1.28M | -110.56%-525K | -95.67%138K |
| Earning before tax | 37.38%2.72B | 19.08%1.42B | -13.21%1.98B | 6.90%1.19B | 21.98%2.28B | 8.89%1.12B | 90.86%1.87B | 25.32%1.03B | -19.94%979.13M | 101.33%818.58M |
| Tax | -27.63%-500.54M | -51.39%-314.28M | -5.78%-392.17M | -26.61%-207.6M | -53.71%-370.74M | -21.62%-163.97M | -15.95%-241.19M | -1.50%-134.83M | 14.32%-208.02M | -39.26%-132.83M |
| After-tax profit from continuing operations | 39.79%2.22B | 12.28%1.11B | -16.90%1.59B | 3.51%986.47M | 17.28%1.91B | 6.96%953.03M | 111.07%1.63B | 29.93%891.03M | -21.33%771.11M | 120.36%685.75M |
| Earning after tax | 39.79%2.22B | 12.28%1.11B | -16.90%1.59B | 3.51%986.47M | 17.28%1.91B | 6.96%953.03M | 111.07%1.63B | 29.93%891.03M | -21.33%771.11M | 120.36%685.75M |
| Minority profit | 243.37%127.23M | 199.54%17.64M | 639.50%37.05M | 142.50%5.89M | 70.99%-6.87M | -75.81%-13.86M | 63.40%-23.67M | 52.90%-7.88M | -1,093.47%-64.69M | -65.81%-16.74M |
| Profit attributable to shareholders | 34.93%2.09B | 11.15%1.09B | -19.13%1.55B | 1.42%980.58M | 16.02%1.92B | 7.56%966.89M | 97.57%1.65B | 27.96%898.91M | -14.16%835.79M | 118.64%702.48M |
| Basic earnings per share | 34.38%0.86 | 12.50%0.45 | -17.95%0.64 | 2.56%0.4 | 20.00%0.78 | 11.43%0.39 | 96.97%0.65 | 25.00%0.35 | -13.16%0.33 | 115.38%0.28 |
| Diluted earnings per share | 37.10%0.85 | 15.38%0.45 | -16.22%0.62 | 5.41%0.39 | 19.35%0.74 | 8.82%0.37 | 87.88%0.62 | 25.93%0.34 | -13.16%0.33 | 107.69%0.27 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
